Bristol-Myers Squibb Company (BMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 4,788,000 | 4,665,000 | 4,322,000 | 2,367,000 | 5,254,000 |
| Cost of Goods | 1,317,000 | 1,225,000 | 1,165,000 | 442,000 | 1,634,000 |
| Gross Profit | 3,471,000 | 3,440,000 | 3,157,000 | 1,925,000 | 3,620,000 |
| Operating Expenses | 1,994,000 | 2,021,000 | 1,985,000 | 1,617,000 | 2,573,000 |
| Operating Income | 1,477,000 | 1,419,000 | 1,172,000 | 308,000 | 1,047,000 |
| Other Income | 88,000 | 103,000 | 23,000 | 885,000 | 108,000 |
| Pre-tax Income | 1,565,000 | 1,522,000 | 1,195,000 | 1,193,000 | 1,155,000 |
| Income Tax | 366,000 | 353,000 | 275,000 | 194,000 | 308,000 |
| Net Income Continuous | 1,199,000 | 1,169,000 | 920,000 | 1,229,000 | 847,000 |
| Net Income Discontinuous | 91,000 | 129,000 | 1,000 | 511,000 | 1,990,000 |
| Minority Interests | 324,000 | 315,000 | 283,000 | 496,000 | 259,000 |
| Net Income | $966,000 | $983,000 | $638,000 | $1,244,000 | $2,578,000 |
| EPS Basic Total Ops | 0.49 | 0.49 | 0.32 | 0.63 | 1.30 |
| EPS Basic Continuous Ops | 0.49 | 0.44 | 0.33 | 0.38 | 0.30 |
| EPS Basic Discontinuous Ops | 0.05 | 0.07 | 0.00 | 0.25 | 1.01 |
| EPS Diluted Total Ops | 0.48 | 0.49 | 0.32 | 0.63 | 1.28 |
| EPS Diluted Continuous Ops | 0.48 | 0.44 | 0.33 | 0.38 | 0.29 |
| EPS Diluted Discontinuous Ops | 0.05 | 0.07 | 0.00 | 0.25 | 0.99 |
| EBITDA(a) | $1,658,000 | $1,596,000 | $1,339,000 | $488,000 | $1,229,000 |